Get Ready, It’s Coming Next Week! What to Expect at COMPUTEX 2021
26.5.2021 10:36:00 EEST | Business Wire | Press release
COMPUTEX 2021 will be launched from May 31 to June 30. The organizer, the Taiwan External Trade Development Council (TAITRA), will roll out the #COMPUTEXVirtual platform to connect the technology community that breaks geographic limitations. COMPUTEX 2021 will offer an exceptional exhibition experience to attendees with the following highlights.
Highlight #1: Top Speakers Will Address on the Groundbreaking Technologies
COMPUTEX 2021 will kick off with the highly anticipated CEO Keynotes. From May 31 to June 2, key industry executives will discuss topics covering AI, high-performance computing (HPC), and other technology trends. Simon Segars, CEO of Arm, Dr. Lisa Su, President and CEO of AMD, Sanjay Mehrotra, President and CEO of Micron, Charles Liang, Founder, President and CEO of Supermicro, and Kurt Sievers, President and CEO of NXP Semiconductors are among the speaker lineup.
The COMPUTEX Forum on June 2 and 3 will revolve around the theme of "The New Era of Intelligence," focusing on key applications of AI, 5G, IoT, and electric vehicles. The forum will unlock the development of quantum computers and explore the infinite possibilities of future technology applications. The world's leading ICT experts will discuss business strategies and pulse industry trends in the post-pandemic era.
Highlight #2: Virtual Booths Will Showcase the Latest Products
#COMPUTEXVirtual, the all-new smart online platform, will use AI and automation technology to create an exceptional digital journey for users by providing a personalized interactive experience. Visitors will be able to obtain the latest product information in real-time.
Acer will showcase its very latest products and innovations that will be announced at its next@acer Global Press Conference to be held on May 27. It will also showcase solutions from its subsidiaries, including products for smart cities, AI, and enterprise use. ZOTAC, on the other hand, will be revealing a brilliant lineup of innovations, including the ZOTAC GAMING GeForce 3090 AMP Extreme Holo graphics card and the MAGNUS ONE ECM53060C mini PC.
Along with the big corporates, innovative startups are always the core elements to drive COMPUTEX and all the industry moving forward. The Epoch Foundation, committed to building partnerships in the global entrepreneurial community, has created a pavilion titled “Garage+ 46 Must-See Startups” on the #COMPUTEXVirtual platform. The exhibition is divided into three sections: “AI & Big Data,” “Digital Health & EdTech,” and “IoT & Energy.”
Moreover, #COMPUTEXVirtual builds #InnoVEXVirtual as a featured exhibit area to help startups connect with the international community. In addition to French Pavilion, Korean Pavilion, and the Dutch Pavilion, the European Bank for Reconstruction and Development (EBRD) is bringing 18 startups from 7 countries to join InnoVEX for the first time.
Highlight #3: Effective Online Platform Functions Will Synergize Matchmaking Opportunities
To maximize the benefits for exhibitors, #COMPUTEXVirtual will provide multiple effective, timely communication channels for exhibitors and visitors, such as video conferencing, meeting requests and instant messaging. Exhibitors can use AI technology to identify target audiences and promote products. Hyper-Personalized Recommendations will also help increase the matchmaking accuracy and enable companies to seize business opportunities effectively.
Together with the technology giants and disruptive startups, COMPUTEX 2021 is ready to bring the world an all-new digital experience. For more exhibition information, please visit the following:
- #COMPUTEXVirtual Online Exhibition Visitor Registration: https://virtual.computextaipei.com.tw/
- COMPUTEX CEO Keynote and COMPUTEX Forum Registration: https://virtual.computextaipei.com.tw/events/
About COMPUTEX TAIPEI (also called COMPUTEX):
Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of the ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.
About COMPUTEX 2021 Virtual:
As a pioneer in technology, COMPUTEX has been at the forefront in embracing digital transformation. In 2021, the show will go online. Together with the key global technology players, the organizer of COMPUTEX,Taiwan External Trade Development Council (TAITRA) introduces #COMPUTEXVirtual (including its global startups and innovations showcase #InnoVEXVirtual), an AI-driven virtual platform, and aims to deliver an exceptional virtual exhibition experience beyond the distance.
About TAITRA:
Founded in 1970, TAITRA is Taiwan's foremost nonprofit trade promoting organization. Sponsored by the government and industry organizations, TAITRA assists enterprises to expand their global reach. Headquartered in Taipei, TAITRA has a team of 1,300 specialists and operates 5 local offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, as well as 63 branches worldwide. Together with Taipei World Trade Center (TWTC) and Taiwan Trade Center (TTC), TAITRA has formed a global network dedicated to promoting world trade.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210526005459/en/
Contact information
For more updates：
COMPUTEX website: https://www.computextaipei.com.tw/
InnoVEX website : https://www.innovex.com.tw/
Press Contacts:
Ms. Tessa Lin <tessalin@taitra.org.tw
Ms. Li Chao < lichao@taitra.org.tw
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 03:00:00 EEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 01:10:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of ORZEYFUL marks a new chapter for the narcolepsy type 1 community, as we introduce an entirely new class of medicine that will potentially redefine how this disease is managed and howpeople feel on treatment,” said Julie Kim, president and chief executive officer of Takeda. “We are proud to have discovered and developed this orexin treatment innovation and will bring it to adults living with NT1 as quickly as possible.” NT1 is a rare, chronic neurological disease d
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 23:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 17:05:00 EEST | Press release
Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership, and operational excellence with a track record of execution from first-in-human studies through regulatory
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom